Health Condition 1: N914- Secondary oligomenorrhea
Conditions
Interventions
None listed
Sponsors
Sir Sunder Lal Hospital faculty Of Ayurveda Institute of Medical Science BHU
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed PCOS as per ROTTERDAM criteria
Exclusion criteria
Exclusion criteria: Women who are currently or have previously used oral contraceptive pills, gluco-corticoids, anti-androgens, ovulation induction medicines, anti-diabetics, anti-obesity drugs, or other hormonal treatments will be excluded from the study unless they have undergone a washout period of 1 month. Women with pelvic inflammatory disease or cervicitis or with evidence of malignancy or cervical intra-epithelial neoplasia or cervical carcinoma; history of untreated sexually transmitted diseases or known to be HIV-positive; pregnant/lactating women. Women with severe sinusitis, visible nasal polyp
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in following Menstrual cycle. Ovarian volume. AMH levels. CRP levels. Antral follicle count and follicular size.Timepoint: 3 regular follow ups with interval of 30 days with medicine and 1 follow up without medicine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in following - BMI status. Health-Related Quality of Life (HRQL) Assessed using a Polycystic Ovarian Syndrome Questionnaire (PCOSQ)Timepoint: 3 regular follow ups with interval of 30 days with medicine and 1 follow up without medicine. | — |
Countries
India
Contacts
Public ContactProf Anuradha Roy
Banaras Hindu University
Outcome results
None listed